Experiment 470943

Worktypes

REVIEW OFANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

TAXOL

Alerts

THESE DATA ARE FROM A REVIEW ARTICLE.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIV
OrganismEmpty organism
CitationARBUCK,SG: CANETTA,R: ONETTO,N: CHRISTIAN,MC:. (1993). CURRENT DOSAGE AND SCHEDULE ISSUES IN THE DEVELOPMENT OF PACLITAXEL (TAXOL).. 20(4)
Amount utilized
Compound isolated
DiseaseREVIEWS PRECLINICAL AND CURRENT CLINICAL TRIALS. SIDE-EFFECTS SEEN INCLUDE HYPERSENSITIVITY, MYELOSUPPRESSION AND NEUROTOXICITY.
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE